Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

I Think, Therefore I Write: Breakthrough Device Turns Thoughts Into Words

Executive Summary

Blackrock Neurotech’s MoveAgain technology platform allows patients who have been silenced by ALS, paralysis and other spinal cord injuries the ability to better communicate via text. The device has been granted breakthrough status by the US FDA.

You may also be interested in...



Money And Materials Will Allow Medtech To Restore Lost Neuro Functions

Medtech Insight spoke to the CEOs Blackrock Neurotech, and Pixium Vision, to find out how their devices can restore lost neurological function, and how devices that interface with the brain may shape the future of medicine.

From The Farm To The OR: Pigs Show More Promise As Organ Donors

Surgeons in Alabama have taken a giant leap forward to making pig kidneys a viable option for humans with end-stage renal disease.

Senators Ask FTC To Investigate COVID-19 Test Price-Gouging

Democrats Markey and Blumenthal say pandemic not only has led to supply shortages but to “predatory and profiteering behavior,” including sales of fraudulent kits or exorbitant prices for approved devices.

Topics

UsernamePublicRestriction

Register

MT144785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel